Induction Chemotherapy and Involved-Field Radiotherapy for Intracranial Germinoma

Journal of Clinical Oncology ◽

10.1200/jco.2002.20.12.2911 ◽

2002 ◽

Vol 20 (12) ◽

pp. 2911-2912 ◽

Author(s):

Arnold C. Paulino ◽

Hidefumi Aoyama ◽

Hiroki Shirato ◽

Masaaki Kashiwamura ◽

Jun Ikeda ◽

...

Keyword(s):

Induction Chemotherapy ◽

Intracranial Germinoma ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

Impact of margin for target volume in low-dose involved field radiotherapy after induction chemotherapy for intracranial germinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.02.024 ◽

2004 ◽

Vol 60 (1) ◽

pp. 214-217 ◽

Author(s):

Hiroki Shirato ◽

Hidefumi Aoyama ◽

Jun Ikeda ◽

Kenji Fujieda ◽

Norio Kato ◽

...

Keyword(s):

Induction Chemotherapy ◽

Low Dose ◽

Target Volume ◽

Intracranial Germinoma ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

Induction Chemotherapy Followed by Low-Dose Involved-Field Radiotherapy for Intracranial Germ Cell Tumors

Journal of Clinical Oncology ◽

10.1200/jco.20.3.857 ◽

2002 ◽

Vol 20 (3) ◽

pp. 857-865 ◽

Author(s):

H. Aoyama

Keyword(s):

Germ Cell ◽

Induction Chemotherapy ◽

Low Dose ◽

Germ Cell Tumors ◽

Intracranial Germ Cell Tumors ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

9228 Involved-Field Radiotherapy (IFRT) after induction chemotherapy with 4–6 cycles of ABVD in early stage (I/IIA) Hodgkin Lymphoma: long term results of a single institution

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71919-6 ◽

2009 ◽

Vol 7 (2) ◽

pp. 568

Author(s):

A. Sotiropoulou ◽

I. Fragandrea ◽

I. Tsalafoutas ◽

M. Bakiri

Keyword(s):

Hodgkin Lymphoma ◽

Induction Chemotherapy ◽

Early Stage ◽

Stage I ◽

Long Term Results ◽

Single Institution ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

Preirradiation evaluation and technical assessment of involved-field radiotherapy using computed tomographic (CT) simulation and neoadjuvant chemotherapy for intracranial germinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(98)00488-x ◽

1999 ◽

Vol 43 (4) ◽

pp. 783-788 ◽

Author(s):

Kei Kitamura ◽

Hiroki Shirato ◽

Yutaka Sawamura ◽

Keishiro Suzuki ◽

Jun Ikeda ◽

...

Keyword(s):

Neoadjuvant Chemotherapy ◽

Intracranial Germinoma ◽

Computed Tomographic ◽

Ct Simulation ◽

Involved Field ◽

Technical Assessment ◽

Involved Field Radiotherapy

Download Full-text

203 oral Efficacy of neoadjuvant chemotherapy and involved-field radiotherapy for the histology-confirmed intracranial germinoma

Radiotherapy and Oncology ◽

10.1016/s0167-8140(01)80344-3 ◽

2001 ◽

Vol 58 ◽

pp. S60

Keyword(s):

Neoadjuvant Chemotherapy ◽

Intracranial Germinoma ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

Patterns of tumor recurrence following induction chemotherapy and involved-field″ radiotherapy (RT) to 70 Gy in stage 3 non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(00)80577-2 ◽

2000 ◽

Vol 29 (1) ◽

pp. 170

Author(s):

J.P van Meerbeeck ◽

S.A Burgers ◽

J van Sornsen de Koste ◽

R.J van Klaveren ◽

M.J Samson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Tumor Recurrence ◽

Small Cell Lung ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(02)03028-6 ◽

2002 ◽

Vol 54 (4) ◽

pp. 999-1006 ◽

Author(s):

Suresh Senan ◽

Sjaak Burgers ◽

Michael J Samson ◽

Rob J van Klaveren ◽

Swie Swat Oei ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell Lung ◽

Elective Nodal Irradiation ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

Concurrent Involved-field Radiotherapy and XELOX Versus XELOX Chemotherapy Alone in Gastric Cancer Patients With Postoperative Locoregional Recurrence

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e31828f5cb6 ◽

2015 ◽

Vol 38 (2) ◽

pp. 130-134 ◽

Author(s):

Shuanghu (Tiger) Yuan ◽

Fu-Li Wang ◽

Ning Liu ◽

Yu-Hui Liu ◽

Shu-Guang Liu ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Locoregional Recurrence ◽

Gastric Cancer Patients ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

Comparison of 30 Gy versus 20 Gy Involved Field Radiotherapy After Two Versus Four Cycles ABVD in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the German Hodgkin Study Group Trial HD10

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.07.008 ◽

2005 ◽

Vol 63 ◽

pp. S1-S2 ◽

Author(s):

H. Eich ◽

R. Mueller ◽

A. Engert ◽

K. Hansemann ◽

R. Skripnitchenko ◽

...

Keyword(s):

Interim Analysis ◽

Hodgkin’S Lymphoma ◽

Early Stage ◽

Hodgkin's Lymphoma ◽

Study Group ◽

German Hodgkin Study Group ◽

Involved Field ◽

Involved Field Radiotherapy ◽

Download Full-text

Low dose (2 × 2 Gy) involved field radiotherapy in recurrent indolent lymphomas induces rapid and lasting remissions without significant toxicity; results of the HORA-1 phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(01)80824-8 ◽

2001 ◽

Vol 37 ◽

pp. S92

Author(s):

R. Haas ◽

B. Aleman ◽

L. Dewit ◽

D. de Jong ◽

H. Bartelink

Keyword(s):

Phase Ii ◽

Low Dose ◽

Phase Ii Study ◽

Significant Toxicity ◽

Indolent Lymphomas ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text